0001209191-15-038051.txt : 20150501
0001209191-15-038051.hdr.sgml : 20150501
20150501170826
ACCESSION NUMBER: 0001209191-15-038051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150429
FILED AS OF DATE: 20150501
DATE AS OF CHANGE: 20150501
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 15825392
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-04-29
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-04-29
4
M
0
1300
17.16
A
387584
D
Common Stock
2015-04-29
4
M
0
10400
35.64
A
397984
D
Common Stock
2015-04-29
4
S
0
4300
123.72
D
393684
D
Common Stock
2015-04-29
4
S
0
4700
124.64
D
388984
D
Common Stock
2015-04-29
4
S
0
2000
125.63
D
386984
D
Common Stock
2015-04-29
4
S
0
700
126.66
D
386284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (right to buy)
17.16
2015-04-29
4
M
0
1300
0.00
D
2015-07-19
Common Stock
1300
14800
D
Stock Option (right to buy)
35.64
2015-04-29
4
M
0
10400
0.00
D
2016-02-01
Common Stock
10400
406400
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $123.72 (range $123.15 to $124.09).
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $124.64 (range $124.17 to $125.16).
Open market sales reported on this line occurred at a weighted average price of $125.63 (range $125.21 to $126.17).
Open market sales reported on this line occurred at a weighted average price of $126.66 (range $126.40 to $127.15).
Common stock held in grantor retained annuity trusts.
Fully vested.
Omar White, Attorney-In-Fact
2015-05-01